ORCHARD THERAPEUTICS PLC.

In News

Charity bringing to EU market gene therapy spurned by pharma - bioworld.com

bioworld.com - Nov 14, 2025

Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel - Yahoo Finance UK

Yahoo Finance UK - Dec 16, 2025

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Pharmaceutical Technology - Jan 25, 2024

Orchard turns to layoffs in cutting gene therapy research - BioPharma Dive

BioPharma Dive - Mar 30, 2022

Slaughter and May is advising Orchard Therapeutics on its recommended cash acquisition by Kyowa Kirin - Slaughter and May

Slaughter and May - Oct 05, 2023

Why The Small Orchard Therapeutics Buyout Is Worth A Look (NASDAQ:ORTX) - Seeking Alpha

Seeking Alpha - Dec 04, 2023

Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin - Nasdaq

Nasdaq - Oct 06, 2023

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics - GSK

GSK - Apr 12, 2018

Why Orchard Therapeutics Stock Is Soaring Today - The Motley Fool

The Motley Fool - Oct 05, 2023

Orchard to lose out on milestone payments as Pharming Group ends collab - The Business Journals

The Business Journals - May 08, 2024

Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium - Stock Titan

Stock Titan - Feb 02, 2024

Orchard Therapeutics plc Stock Price, News, Quote & History - Investing News Network

Investing News Network - Dec 06, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment